Medicare Enrolled
Dr. Michael Curran, M.D.
Urology Physician · Norwood, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Curran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Curran?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Curran
Dr. Michael Curran is an urology physician in Norwood, MA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Curran performed 8,274 Medicare services across 4,742 unique beneficiaries.
Between the years covered by Open Payments, Dr. Curran received a total of $12,601 from 64 pharmaceutical and/or device companies across 470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Curran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 8% volume in MA
$12,601 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,274
Medicare services
Top 8% in MA for urology physician
4,742
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~394 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,406 | $2 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,272 | $101 | $350 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
702 | $34 | $85 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
637 | $57 | $260 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
447 | $9 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
381 | $70 | $245 |
| PSA test (prostate cancer screening) | 359 | $18 | $100 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
342 | $8 | $25 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
218 | $6 | $278 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 216 | $137 | $750 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
213 | $211 | $725 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
203 | $79 | $292 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
183 | $53 | $85 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
155 | $25 | $89 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
124 | $102 | $387 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
116 | $45 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
105 | $124 | $478 |
| Injection, garamycin, gentamicin, up to 80 mg | 97 | $2 | $15 |
| 3D radiographic procedure with computerized image postprocessing A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data. |
76 | $42 | $247 |
| Simple change of bladder tube | 73 | $78 | $300 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
68 | $60 | $209 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
55 | $26 | $141 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
54 | $34 | $85 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
54 | $34 | $85 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
53 | $41 | $85 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
52 | $18 | $100 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
51 | $73 | $450 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
49 | $203 | $800 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
47 | $11 | $90 |
| Tumor marker analysis A laboratory test that analyzes a sample to detect the presence of tumor markers. These markers are substances that may be found in the blood, urine, or body tissues. |
44 | $20 | $50 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
36 | $52 | $300 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
36 | $5 | $20 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
35 | $8 | $25 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
35 | $4 | $15 |
| Insertion of temporary bladder tube | 34 | $40 | $200 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
31 | $66 | $289 |
| Total calcium level test A blood test that measures the total amount of calcium in your body. |
25 | $5 | $15 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
21 | $18 | $402 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
21 | $112 | $433 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
21 | $8 | $25 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
20 | $196 | $671 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
18 | $21 | $50 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $83 | $300 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
16 | $28 | $85 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
15 | $168 | $3,500 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
15 | $587 | $2,310 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
14 | $511 | $3,214 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $92 | $375 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,601
Total received (2018-2024)
Avg $1,800/year across 7 years
Top 14% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
470
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,801 (69.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,800 (30.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,757
2023
$1,021
2022
$1,124
2021
$1,258
2020
$1,079
2019
$4,410
2018
$1,952
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
IMMUNITYBIO, INC.
$229
Astellas Pharma US Inc
$190
Sumitomo Pharma America, Inc.
$134
Tolmar, Inc.
$121
IntrinsiQ Specialty Solutions, Inc.
$89
180 Medical, Inc.
$88
Endo USA, Inc.
$78
Endo Pharmaceuticals Inc.
$72
Ferring Pharmaceuticals Inc.
$69
BLUEWIND MEDICAL
$61
UROGEN PHARMA, INC.
$55
Merck Sharp & Dohme LLC
$52
Teleflex LLC
$51
Telix Pharmaceuticals
$46
PFIZER INC.
$41
Myriad Genetic Laboratories, Inc.
$41
PROGENICS PHARMACEUTICALS, INC.
$40
Agiliti Surgical, Inc.
$34
Novartis Pharmaceuticals Corporation
$33
Boston Scientific Corporation
$32
Verity Pharmaceuticals Inc.
$30
Antares Pharma, Inc.
$26
Novo Nordisk Inc
$25
Hollister Incorporated
$23
ABC Home Medical Supply, Inc.
$23
ABBVIE INC.
$22
Janssen Biotech, Inc.
$22
Tempus AI, Inc
$19
COLOPLAST CORP
$14
Top 3 companies account for 31.5% of 2024 payments
All-time payments by company (2018-2024) ›
Blue Earth Diagnostics Limited
$3,223
Astellas Pharma US Inc
$1,312
PFIZER INC.
$813
Janssen Biotech, Inc.
$735
Dendreon Pharmaceuticals LLC
$672
Amgen Inc.
$440
Endo Pharmaceuticals Inc.
$413
NeoTract Inc.
$313
IMMUNITYBIO, INC.
$229
180 Medical, Inc.
$227
TOLMAR Pharmaceuticals, Inc.
$215
UROVANT SCIENCES INC
$204
Ferring Pharmaceuticals Inc.
$190
Tolmar, Inc.
$177
Antares Pharma, Inc.
$176
Sumitomo Pharma America, Inc.
$176
AbbVie, Inc.
$145
AbbVie Inc.
$132
Sun Pharmaceutical Industries Inc.
$126
Laborie Medical Technologies Corp.
$125
Progenics Pharmaceuticals, Inc.
$123
UROGEN PHARMA, INC.
$123
Myriad Genetic Laboratories, Inc.
$119
C. R. Bard, Inc. & Subsidiaries
$119
UroGen Pharma, Inc.
$119
Boston Scientific Corporation
$116
Acerus Pharmaceuticals Corporation
$103
Novartis Pharmaceuticals Corporation
$92
Merck Sharp & Dohme LLC
$91
IntrinsiQ Specialty Solutions, Inc.
$89
DENTSPLY IH Inc.
$88
Avadel Specialty Pharmaceuticals, LLC
$86
AMAG Pharmaceuticals, Inc.
$86
Hollister Incorporated
$83
Merck Sharp & Dohme Corporation
$79
Endo USA, Inc.
$78
Rochester Medical Corporation
$71
Telix Pharmaceuticals
$63
BLUEWIND MEDICAL
$61
Agiliti Surgical, Inc.
$55
Teleflex LLC
$51
AstraZeneca Pharmaceuticals LP
$50
ABBVIE INC.
$50
Travere Therapeutics, Inc.
$47
Egalet US Inc
$42
Axonics, Inc.
$41
Retrophin, Inc.
$41
PROGENICS PHARMACEUTICALS, INC.
$40
Myovant Sciences Inc.
$37
BOSTON SCIENTIFIC CORPORATION
$33
COLOPLAST CORP
$31
Verity Pharmaceuticals Inc.
$30
GENZYME CORPORATION
$26
Novo Nordisk Inc
$25
Supernus Pharmaceuticals, Inc.
$24
ABC Home Medical Supply, Inc.
$23
Metuchen Pharmaceuticals
$20
Tempus AI, Inc
$19
Palette Life Sciences, Inc.
$15
Aytu Bioscience, Inc
$15
Aytu BioScience, Inc
$14
Coloplast Corp
$14
C. R. BARD, INC. & SUBSIDIARIES
$14
Hologic, LLC
$12
Top 3 companies account for 42.4% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS · ANKTIVA · AVEED · Aptima Trichomonas · Axonics · Axonics r-SNM System · Axumin · BOTOX · Bard Urinary Drainage Bag · CURE CATHETER · ELIGARD · ERLEADA · ESTRING · EVENITY · Erleada · FIRMAGON · GARDASIL 9 · GEMTESA · GENERAL - BPH · GENTLECATH · ILLUCCIX · INLAY OPTIMA · INTRAROSA · Infyna Chic · JELMYTO · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Luja Coude · Lupron · MAGIC3 · MYRBETRIQ · MYRISK · Myrbetriq · NOCDURNA · Natesto · Noctiva · ORGOVYX · OTREXUP · Otrexup · PLUVICTO · PREMARIN · PREMPRO · PROLARIS · PROVENGE · PVC · PYLARIFY · Prolaris · Prolia · REVI · REZUM · Rivfloza · SKYLITE · SOLTIVE · SOLYX · SPEEDICATH · SPRIX · Sonablate HIFU · SpeediCath · Stendra · TLANDO · TOVIAZ · Trelstar · UROLIFT · UroLift · VaPro Plus Pocket · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (70%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
196
Per 100K population
27.1
County median income
$126,497
Nearest hospital
NORWOOD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Curran is a clinical cardiology specialist, with above-average Medicare volume (top 8% in MA), with low-engagement industry engagement in the top 14% of MA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Curran experienced with automated urinalysis?
Based on Medicare claims data, Dr. Curran performed 1,406 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Curran receive payments from pharmaceutical companies?
Yes. Dr. Curran received a total of $12,601 from 64 companies across 470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Curran's costs compare to other urology physicians in Norwood?
Dr. Curran's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Curran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Norwood
Browse urology physicians in Norwood ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MA
Which MA urology physicians receive the most from drug and device companies.
By company
Blue Earth Diagnostics Limited Payments to Doctors
See all physicians who received payments from Blue Earth Diagnostics Limited.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology